• Guideline Summary
  • NGC:010373
  • 2013 Sep

Optimal use of taxanes in metastatic breast cancer (MBC).

  • Guideline Summary
  • NGC:009893
  • 2013 May

Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.

  • Guideline Summary
  • NGC:010250
  • 2011 Jan (revised 2013 Oct)

Nonmuscle invasive bladder cancer.

  • Guideline Summary
  • NGC:009216
  • 2012

ACR Appropriateness Criteria® definitive therapy for early stage cervical cancer.

  • Guideline Summary
  • NGC:010624
  • 2005 Aug (revised 2014 Dec)

Colorectal cancer. The diagnosis and management of colorectal cancer.

  • Guideline Summary
  • NGC:009858
  • 2001 Sep 21 (revised 2011 Nov 21)

Optimal chemotherapy for recurrent ovarian cancer.

  • Guideline Summary
  • NGC:009295
  • 2004 Aug (revised 2012 Aug)

Practice parameters for the management of colon cancer.

  • Guideline Summary
  • NGC:010080
  • 2003 Oct (revised 2013 Nov)

Management of epithelial ovarian cancer. A national clinical guideline.

  • Guideline Summary
  • NGC:008662
  • 2005 Feb (revised 2011 Apr)

Lung cancer. The diagnosis and treatment of lung cancer.

  • Guideline Summary
  • NGC:010199
  • 2010 (revised 2013 Nov)

British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

  • Guideline Summary
  • NGC:010403
  • 2011 Jan 28 (revised 2014)

Preexposure prophylaxis for the prevention of HIV Infection in the United States - 2014.

  • Guideline Summary
  • NGC:009311
  • 2012 Aug

Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

  • Guideline Summary
  • NGC:010683
  • 2014

ACR Appropriateness Criteria® resectable stomach cancer.

  • Guideline Summary
  • NGC:010700
  • 2014 Sep 30

Optimal systemic therapy for early female breast cancer.

  • Guideline Summary
  • NGC:010257
  • 2010 Aug (revised 2012 Dec)

Malignant pleural mesothelioma.

  • Guideline Summary
  • NGC:010809
  • 1997 May (revised 2015 Oct 20)

Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update.

  • Guideline Summary
  • NGC:010330
  • 2013 Dec

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.

  • Guideline Summary
  • NGC:009558
  • 2003 Mar (revised 2012 Oct)

HIV prophylaxis following occupational exposure.